Abstract
Two new photoactivatable carbon monoxide‐releasing molecules (CORMs), fac‐[Mn(CO)3(BZM)Br] (1) and [RuCl2(BZM)(CO)2] (2), derived from the anti‐anxiety drug bromazepam (BZM) and capable of rapid release of CO upon the illumination with light‐emitting diode (LED) source light (470–525 nm) have been synthesized and characterized. The photo‐delivery of CO to myoglobin solution could be achieved via the illumination of 1 at 525 nm for 10 min or at 470 nm for 1 min. The addition of water to a dimethylsulfoxide (DMSO) solution of 1 increases its stability, but it decreases the rate of the CO‐releasing process. CORM 2 behaves as a good visible photoCORM, whereby its two CO molecules are released within 10 min upon exposure to LED light source at 470 nm in DMSO. The illumination profile of 2 was also examined using solution infrared spectroscopy. The cis/trans stereochemistry around the Ru(II) ion was determined using quantum chemical calculations. The formation of photoCORMs leads to an improvement in the toxicity of BZM against tested microbes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.